Back to Trades
Ghias Babar
Chief Financial OfficerCIK 0002076862
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025
Across 2 filings between 2025, Ghias Babar, Chief Financial Officer, has disclosed $5.1M in transactions — all concentrated in BIOCRYST PHARMACEUTICALS INC (BCRX). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Dec 19 | BCRX BIOCRYST PHARMACEUTICALS INC | Ghias Babar | Chief Financial Officer | Grant | $2.5M |
| Jul 28 | BCRX BIOCRYST PHARMACEUTICALS INC | Ghias Babar | CFO & Head of Corp Development | Grant | $2.6M |
2 filings